The present disclosure relates to novel 1,3,5 tri-substituted benzenes of general formula (I), (II) or (III) and the use of such compounds in the treatment of diseases associated with the deposition of -amyloid in the brain.
本公开涉及新颖的一般式(I),(II)或(III)的1,3,5三取代
苯,并且这些化合物在治疗与β-淀粉样蛋白在大脑中沉积相关的疾病中的应用。